Clinical, Hormonal, and Metabolic Parameters in Women with Subclinical Hypothyroidism and Polycystic Ovary Syndrome: A Cross-Sectional Study

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Women's Health

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jwh.2017.6584PMID 29620956
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk

  2016cited by this paper
• Subclinical hypothyroidism in patients with polycystic ovary syndrome: distribution and its association with lipid profiles.

  2014influential reference
• Clinical characteristics of polycystic ovary syndrome in Indian women

  2013cited by this paper
• Alterations in thyroid function among the different polycystic ovary syndrome phenotypes

  2013cited by this paper
• Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.

  2013cited by this paper
• High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome.

  2013cited by this paper
• Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India

  2013cited by this paper
• Subclinical hypothyroidism is associated with increased risk for all-cause and cardiovascular mortality in adults.

  2012cited by this paper
• Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?

  2012cited by this paper
• Thyroid disease in pregnancy.

  2011cited by this paper
• 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum

  2011cited by this paper
• Association of subclinical hypothyroidism and phenotype, insulin resistance, and lipid parameters in young women with polycystic ovary syndrome.

  2011influential reference
• Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy.

  2010cited by this paper
• Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

  2010cited by this paper
• What is a normal thyroid-stimulating hormone (TSH) level? Effects of stricter TSH thresholds on pregnancy outcomes after in vitro fertilization.

  2010influential reference
• Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS.

  2009influential reference
• Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.

  2009influential reference
• Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.

  2008influential reference
• Prevalence of subclinical hypothyroidism in patients with metabolic syndrome.

  2007cited by this paper
• Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline.

  2007cited by this paper
• Insulin action in adipose tissue and muscle in hypothyroidism.

  2006cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.

  2004influential reference
• Use and abuse of HOMA modeling.

  2004cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

  2004cited by this paper
• High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.

  2004cited by this paper
• Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease

  2003influential reference
• The Prevalence of Undiagnosed Thyroid Disorders in a Previously Iodine-Deficient Area

  2003cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

  2003cited by this paper
• Long-term health consequences of PCOS.

  2002cited by this paper
• Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

  2002cited by this paper
• Polycystic ovary syndrome: the new millenium

  2001cited by this paper
• Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.

  2001cited by this paper
• American Thyroid Association guidelines for detection of thyroid dysfunction.

  2000cited by this paper
• Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

  1999cited by this paper
• The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey

  1995cited by this paper
• Intra- and interindividual biological variation of five analytes used in assessing thyroid function: implications for necessary standards of performance and the interpretation of results.

  1986cited by this paper
• Thyroid disease in pregnancy.

  1966influential reference
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected

  year unknowncited by this paper

• A Review of Traditional and Non-Traditional Cardiovascular Risk Factors in Women.

  2026cites this paper
• Subclinical Hypothyroidism in Polycystic Ovary Syndrome: Prevalence and Impact on Metabolic and Cardiovascular risk

  2025cites this paper
• Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: An updated meta-analysis of cohort studies

  2025cites this paper
• Polycystic Ovary Syndrome and Insulin Resistance: Comparative Analysis of Obese and Non-Obese Women in a Tertiary Care Setting Pakistan

  2025cites this paper
• Prevalence of subclinical hypothyroidism in polycystic ovary syndrome and its impact on insulin resistance: a systematic review and meta-analysis

  2025cites this paper
• Impact of subclinical hypothyroidism on clinical, hormonal, and metabolic parameters in women with polycystic ovary syndrome: the role of levothyroxine therapy

  2025cites this paper
• The effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study

  2024cites this paper
• Is thyroid function associated with polycystic ovary syndrome? A bidirectional Mendelian randomization study

  2024cites this paper
• Adipose Tissue Dysfunction in PCOS

  2024cites this paper
• Thyroid disease and autoimmunity in obese patients: a narrative review.

  2023cites this paper
• Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis

  2023cites this paper
• Association of polycystic ovary syndrome with cardiovascular disease among US female hospitalizations.

  2023cites this paper
• Клінічна характеристика жінок з гіперплазією ендометрія на тлі дисфункції щитоподібної залози

  2022cites this paper
• Association of Subclinical Hypothyroidism with Present and Absent Anti-Thyroid Antibodies with PCOS Phenotypes and Metabolic Profile

  2022cites this paper
• The Associations Between Alanine Aminotransferase and Other Biochemical Parameters in Lean PCOS

  2022cites this paper
• Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review

  2022cites this paper
• A Study on the Association between Subclinical Hypothyroidism and Polycystic Ovary Syndrome Advances in Bioengineering & Biomedical Science Research

  2022cites this paper
• Clinical characteristics of women with endometrial hyperplasia on the background of thyroid dysfunction

  2022cites this paper
• Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto’s Thyroiditis: How Far Is Our Understanding?

  2021cites this paper
• The Influence of Treated and Untreated Subclinical Hypothyroidism on Metabolic Profile in Women with Polycystic Ovary Syndrome

  2021cites this paper
• A Study on the Association Between Subclinical Hypothyroidism and Polycystic Ovary Syndrome

  2021cites this paper
• Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome

  2021cites this paper
• Total cholesterol/HDL cholesterol ratio and monocyte/HDL cholesterol ratio are related with subclinical hypothyroidism in polycystic ovary syndrome

  2021cites this paper
• The Impact of Subclinical Hypothyroidism on Patients with Polycystic Ovary Syndrome: A Meta-Analysis

  2021cites this paper
• Effects of hypothyroidism in Indian women of reproductive age group – A review article

  2020cites this paper
• Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies

  2020cites this paper
• Correlation of Subclinical Hypothyroidism With Polycystic Ovary Syndrome (PCOS)

  2020influential citation
• Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

  2018cites this paper